Highlights and difficulties in surgical treatment for pancreatic carcinoma
10.3760/cma.j.issn.1673-9752.2015.08.004
- VernacularTitle:胰腺癌外科治疗的热点与难点
- Author:
Yinmo YANG
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Surgical therapy;
Neoadjuvant therapy
- From:
Chinese Journal of Digestive Surgery
2015;14(8):612-614
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic carcinoma is still a challenging disease,although the resection rate and the operative safety have been improved,the prognosis of the patients is dismal.Now the therapy strategy is changed from surgery first into the mode of multidisciplinary team (MDT).Surgical resection is the only curable therapy for pancreatic carcinoma.Recently,the clinical role of extent of lymphadenectomy,combined vascular resection,and total mesopancreas excision was recognized more deeply.If 1 mm rule is applied to define the resection margin,most pancreatic cancer resections are R1 resections,which benefit the patients.There has been consensus on the definition of perioperative complications.Neoadjuvant therapy is advocated for patients with borderline resectable pancreatic carcinoma.
